ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01302847
Recruitment Status : Recruiting
First Posted : February 24, 2011
Last Update Posted : May 25, 2018
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 30, 2020
  Estimated Study Completion Date : June 30, 2025
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):